SecBot SecBot

AMWL

American Well Corp
NYSE· Services-Business Services, NEC· Inc. DE· CIK 0001393584 Software & IT
$11.34 −0.40 (−3.41%)
Nov 16 4:00 PM ET · prev $11.74
Market cap
$208.0M
Micro cap
Consensus
Buy
40% Buy or better · 15 analysts
Median target
$13.00
+15% · range $12.00–18.00
1 year
+186.4%
from $3.96 · Nov 17
30 days
−8.0%
from $12.33
52-week range
$3.78–14.98
−24% from high · low Nov 20
Avg volume 20D
137.5K
shares / day
Short interest
250.2K
≈1.4% of shares · +21.1%
Days to cover
1.7
at average volume
Insider net
−$980.4K
1 buyer · 5 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
17
analyzed by SecBot
SecBot read MIXED 6 reports · 90 days
Balance 0 bearish · 0 bullish · 6 neutral oldest → newest, height = score
Avg score ·High conf. 5/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $4.9K at an average $7.37. 5 insiders sold $985.3K. Price is 54% above their cost.

  • InstitutionsMIXED

    Q3 2026: 7 added (0 new), 5 trimmed or exited.

  • AnalystsBULLISH

    6 of 15 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.440 → −$0.350 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersBUILDING

    Short interest +21.1% to 250.2K shares. 1.7 days to cover, ≈1.4% of shares.

  • TrendDOWNTREND

    12% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCADD397,323$5.4M
MARSHALL WACE, LLPDOUBLED355,660$4.8M
BlackRock, Inc.TRIM313,180$4.3M
JANE STREET GROUP, LLCTRIM40,055$543.9K
AMERICAN CENTURY COMPANIES INCADD19,019$258.3K
IMC-Chicago, LLCADD16,314$221.5K
JPMORGAN CHASE & CODOUBLED8,638$113.5K
UBS Group AGNEAR_EXIT5,060$68.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 40% rate it Buy or better
Strong Buy2Buy4Hold9Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +15%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 4, 2026TD Cowen
MAINTAIN
MAINTAINHold
Nov 4, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 4, 2026Stifel
MAINTAIN
MAINTAINHold
Aug 13, 2026Truist Securities
MAINTAIN
MAINTAINHold
Aug 5, 2026Needham
REITERATE
REITERATEHold
Jul 17, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$4.9K
bought · 1 insider
$985.3K
sold · 5 insiders
+53.9%
vs their $7.37 cost
DateInsiderTypeValue
Oct 1, 2026
McNeice Paul Francis
Chief Accounting Officer
Oct 1, 2026
SELL$8.5K
Oct 1, 2026
Zamansky Dmitry
Chief Product & Tech. Officer
Oct 1, 2026
SELL$109.7K
Oct 1, 2026
HIRSCHHORN MARK
Chief Financial Officer
Oct 1, 2026
SELL$55.7K
Oct 1, 2026
Gotlib Phyllis
President, International
Oct 1, 2026
SELL$86.8K
Sep 1, 2026
HIRSCHHORN MARK
Chief Financial Officer
Sep 1, 2026
SELL$126.9K
Sep 1, 2026
McNeice Paul Francis
Chief Accounting Officer
Sep 1, 2026
SELL$1.3K
Sep 1, 2026
Gotlib Phyllis
President, International
Sep 1, 2026
SELL$42.2K
Jul 1, 2026
Zamansky Dmitry
Chief Product & Tech. Officer
Jul 1, 2026
SELL$78.9K

Earnings setup

Estimates
−$0.35
EPS estimate, this quarter
+20%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.35-$0.35–-$0.35+20.5%$49.3M
Next Q-$0.49-$0.65–-$0.26+8.5%$54.7M
Current FY-$2.46-$2.46–-$2.46+3.9%$205.2M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
250,235
shares short
+21.1%
vs prior settlement
1.7
days to cover
≈1.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Amwell filed additional definitive proxy soliciting materials (DEFA14A) urging shareholders to vote FOR a proposal to…
DEFA14A · Impact 3/10
Nov 13, 2026 SEC
Amwell is seeking shareholder approval at a December 29, 2026 special meeting to increase shares authorized under its…
DEF 14A · Impact 3/10
Nov 10, 2026 Other
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Healt
Nov 3, 2026 SEC
Amwell reported Q3 2026 revenue of $49.0M, above the $47.3M consensus, but GAAP net loss widened to ($11.0M) from…
8-K · Impact 5/10
Oct 1, 2026 Insider
McNeice Paul Francis sold 653 shares
Chief Accounting Officer @ $13.00 ($8.5K)
Oct 1, 2026 Insider
Zamansky Dmitry sold 8,442 shares
Chief Product & Tech. Officer @ $13.00 ($109.7K)
Oct 1, 2026 Insider
HIRSCHHORN MARK sold 4,282 shares
Chief Financial Officer @ $13.00 ($55.7K)
Sep 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC · ADD
397,323 shares ($5.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 10, 2026
Press release
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
Nov 6, 2026
Press release
Amwell makes grant to new employees under inducement plan
BOSTON, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for…
Nov 3, 2026
Earnings result
AMWL Q3 2026 Earnings: EPS $-0.67 (+12.7% vs est)
Sep 8, 2026
Contract
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
Amwell receives Letter of Intent from Department of Veterans Affairs to be its enterprise virtual health platform.
Sep 3, 2026
Company news
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026…

SecBot reports

17 filings · 1 press release · 0 bullish · 1 bearish · 2 mixed · 14 neutral
All AMWL filing & press-release reports (18)